TY - JOUR T1 - Safety and efficacy of 4-terpineol against microorganisms associated with blepharitis and common ocular diseases JF - BMJ Open Ophthalmology DO - 10.1136/bmjophth-2017-000094 VL - 3 IS - 1 SP - e000094 AU - Chen-Wei Su AU - Sean Tighe AU - Hosam Sheha AU - Anny M S Cheng AU - Scheffer C G Tseng Y1 - 2018/06/01 UR - http://bmjophth.bmj.com/content/3/1/e000094.abstract N2 - Objective Microbial infection has been reported to cause blepharitis, conjunctivitis and keratitis. We evaluated the safety and efficacy of a foam formulation of 2% 4-terpineol (T4O) against common ocular microorganisms.Material and methods The antimicrobial effect of a 2% T4O formulation was evaluated by the United States Pharmacopeia 51 (USP <51>) antimicrobial effectiveness test for 14 and 28 days, as well as by a Time Kill Study (ASTM E2315) with a 60 s exposure time. Its potential of causing skin and ocular irritation was evaluated by the Repeated Insult Patch Test and the Hen’s Egg Chorioallantoic Membrane Test, respectively.Results and discussion It was seen that 2% T4O formulation did not cause ocular irritation, skin irritation, sensitisation or allergic contact dermatitis in human subjects. Most importantly, it killed microorganisms listed in USP <51> at both 14 and 28 days and exerted a rapid killing effect within 60 s against 13 bacteria, 1 fungus and Acanthamoeba castellanii.Conclusion The above finding suggests that 2% T4O formulation is safe and effective in killing microorganisms related to common ocular and skin infective diseases.Translational relevance Although the clinical efficacy in treating ocular disease was not directly studied; this foam formulation containing 2% T4O, based on the in vitro results of this work, demonstrated that it can potentially be used as a preservative-free cleansing agent for ocular hygiene maintenance due to its ability to exert a broad-spectrum antimicrobial effect without causing ocular or skin irritation. ER -